Atrial Tachyarrhythmia in Rgs5-null Mice

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Nov 13

PMID 23144791

Citations 7

Authors

Mu Qin

He Huang

Teng Wang

He Hu

Yu Liu

Yongwei Gu

Hong Cao

Hongliang Li

Congxin Huang

Affiliations

Soon will be listed here.

Abstract

Aims: The aim of this study was to elucidate the effects of regulator of G-protein signaling 5 (Rgs5), a negative regulator of G protein-mediated signaling, on atrial repolarization and tachyarrhythmia (ATA) in mice.

Methods And Results: In present study, the incidence of ATA were increased in Rgs5(-/-) Langendorff-perfused mouse hearts during program electrical stimulation (PES) (46.7%, 7 of 15) and burst pacing (26.7%, 4 of 15) compared with wild-type (WT) mice (PES: 7.1%,1 of 14; burst:7.1%,1 of 14) (P<0.05). And the duration of ATA also shown longer in Rgs5(-/-) heart than that in WT, 2 out of 15 hearts exhibited sustained ATA (>30 s) but none of them observed in WT mice. Atrial prolonged repolarization was observed in Rgs5(-/-) hearts including widened P wave in surface ECG recording, increased action potential duration (APD) and atrial effective refractory periods (AERP), all of them showed significant difference with WT mice (P<0.05). At the cellular level, whole-cell patch clamp recorded markedly decreased densities of repolarizing K(+) currents including I(Kur) (at +60 mV: 14.0±2.2 pF/pA) and I(to) (at +60 mV: 16.7±1.3 pA/pF) in Rgs5(-/-) atrial cardiomyocytes, compared to those of WT mice (at +60 mV I(to): 20.4±2.0 pA/pF; I(kur): 17.9±2.0 pF/pA) (P<0.05).

Conclusion: These results suggest that Rgs5 is an important regulator of arrhythmogenesis in the mouse atrium and that the enhanced susceptibility to atrial tachyarrhythmias in Rgs5(-/-) mice may contribute to abnormalities of atrial repolarization.

Citing Articles

Associations of and Gene Polymorphisms with the Risk of Ritodrine-Induced Adverse Events in Korean Women with Preterm Labor: A Cohort Study.

Jang E, Kim Y, Hwang H, Yee J, Gwak H Pharmaceutics. 2022; 14(6).

PMID: 35745791 PMC: 9227008. DOI: 10.3390/pharmaceutics14061220.

A Mathematical Model of the Mouse Atrial Myocyte With Inter-Atrial Electrophysiological Heterogeneity.

Zhang H, Zhang S, Wang W, Wang K, Shen W Front Physiol. 2020; 11:972.

PMID: 32848887 PMC: 7425199. DOI: 10.3389/fphys.2020.00972.

Distinct Occurrence of Proarrhythmic Afterdepolarizations in Atrial Versus Ventricular Cardiomyocytes: Implications for Translational Research on Atrial Arrhythmia.

Bogeholz N, Pauls P, Dechering D, Frommeyer G, Goldhaber J, Pott C Front Pharmacol. 2018; 9:933.

PMID: 30186171 PMC: 6111493. DOI: 10.3389/fphar.2018.00933.

Electrophysiological Mechanisms of Bayés Syndrome: Insights from Clinical and Mouse Studies.

Tse G, Lai E, Yeo J, Yan B Front Physiol. 2016; 7:188.

PMID: 27303306 PMC: 4886053. DOI: 10.3389/fphys.2016.00188.

Potential Role of Regulator of G-Protein Signaling 5 in the Protection of Vagal-Related Bradycardia and Atrial Tachyarrhythmia.

Qin M, Liu X, Liu T, Wang T, Huang C J Am Heart Assoc. 2016; 5(3):e002783.

PMID: 26961238 PMC: 4943254. DOI: 10.1161/JAHA.115.002783.

References

Dautova Y, Zhang Y, Sabir I, Grace A, Huang C . Atrial arrhythmogenesis in wild-type and Scn5a+/delta murine hearts modelling LQT3 syndrome. Pflugers Arch. 2009; 458(3):443-57. PMC: 2691533. DOI: 10.1007/s00424-008-0633-z. View

Tuomi J, Chidiac P, Jones D . Evidence for enhanced M3 muscarinic receptor function and sensitivity to atrial arrhythmia in the RGS2-deficient mouse. Am J Physiol Heart Circ Physiol. 2009; 298(2):H554-61. DOI: 10.1152/ajpheart.00779.2009. View

Posokhova E, Wydeven N, Allen K, Wickman K, Martemyanov K . RGS6/Gβ5 complex accelerates IKACh gating kinetics in atrial myocytes and modulates parasympathetic regulation of heart rate. Circ Res. 2010; 107(11):1350-4. PMC: 3014848. DOI: 10.1161/CIRCRESAHA.110.224212. View

Chen Y, Xu S, Bendahhou S, Wang X, Wang Y, Xu W . KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science. 2003; 299(5604):251-4. DOI: 10.1126/science.1077771. View

Reil J, Hohl M, Oberhofer M, Kazakov A, Kaestner L, Mueller P . Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling. Cardiovasc Res. 2010; 87(3):485-93. DOI: 10.1093/cvr/cvq079. View

Thilen U, Carlson J, Platonov P, Havmoller R, Bertil Olsson S . Prolonged P wave duration in adults with secundum atrial septal defect: a marker of delayed conduction rather than increased atrial size?. Europace. 2007; 9 Suppl 6:vi105-8. DOI: 10.1093/europace/eum214. View

Mangoni M, Traboulsie A, Leoni A, Couette B, Marger L, Le Quang K . Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/alpha1G T-type calcium channels. Circ Res. 2006; 98(11):1422-30. DOI: 10.1161/01.RES.0000225862.14314.49. View

de Boer R, Pokharel S, Flesch M, van Kampen D, Suurmeijer A, Boomsma F . Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27. J Mol Med (Berl). 2004; 82(10):678-87. DOI: 10.1007/s00109-004-0579-3. View

Nattel S, Shiroshita-Takeshita A, Brundel B, Rivard L . Mechanisms of atrial fibrillation: lessons from animal models. Prog Cardiovasc Dis. 2005; 48(1):9-28. DOI: 10.1016/j.pcad.2005.06.002. View

10.

Rivard K, Paradis P, Nemer M, Fiset C . Cardiac-specific overexpression of the human type 1 angiotensin II receptor causes delayed repolarization. Cardiovasc Res. 2008; 78(1):53-62. DOI: 10.1093/cvr/cvn020. View

11.

Nattel S . G-protein signaling and arrhythmogenic atrial remodeling: relevance to novel therapeutic targets in atrial fibrillation. Heart Rhythm. 2009; 6(1):85-6. DOI: 10.1016/j.hrthm.2008.11.028. View

12.

Hayabuchi Y, Davies N, Standen N . Angiotensin II inhibits rat arterial KATP channels by inhibiting steady-state protein kinase A activity and activating protein kinase Ce. J Physiol. 2001; 530(Pt 2):193-205. PMC: 2278407. DOI: 10.1111/j.1469-7793.2001.0193l.x. View

13.

Nerbonne J . Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium. J Physiol. 2000; 525 Pt 2:285-98. PMC: 2269952. DOI: 10.1111/j.1469-7793.2000.t01-1-00285.x. View

14.

Li H, He C, Feng J, Zhang Y, Tang Q, Bian Z . Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload. Proc Natl Acad Sci U S A. 2010; 107(31):13818-23. PMC: 2922261. DOI: 10.1073/pnas.1008397107. View

15.

Goette A, Lendeckel U, Klein H . Signal transduction systems and atrial fibrillation. Cardiovasc Res. 2002; 54(2):247-58. DOI: 10.1016/s0008-6363(01)00521-1. View

16.

Zhang T, Takimoto K, Stewart A, Zhu C, Levitan E . Independent regulation of cardiac Kv4.3 potassium channel expression by angiotensin II and phenylephrine. Circ Res. 2001; 88(5):476-82. DOI: 10.1161/01.res.88.5.476. View

17.

Domenighetti A, Boixel C, Cefai D, Abriel H, Pedrazzini T . Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation. J Mol Cell Cardiol. 2006; 42(1):63-70. DOI: 10.1016/j.yjmcc.2006.09.019. View

18.

Shimoni Y . Inhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetes. J Physiol. 2001; 537(Pt 1):83-92. PMC: 2278945. DOI: 10.1111/j.1469-7793.2001.0083k.x. View

19.

Nattel S, Burstein B, Dobrev D . Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol. 2009; 1(1):62-73. DOI: 10.1161/CIRCEP.107.754564. View

20.

Benjamin E, Wolf P, DAgostino R, Silbershatz H, Kannel W, Levy D . Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998; 98(10):946-52. DOI: 10.1161/01.cir.98.10.946. View